NEUPOGEN

This brand name is authorized in Australia, Canada, Germany, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Ireland, Israel, Lithuania, Netherlands, New Zealand, Poland, Singapore, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug NEUPOGEN contains one active pharmaceutical ingredient (API):

1 Filgrastim UNII PVI5M0M1GW - FILGRASTIM

Filgrastim causes marked increases in peripheral blood neutrophil counts within 24 hours, with minor increases in monocytes. Read about Filgrastim

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
NEUPOGEN Solution for injection	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L03AA02	Filgrastim	L Antineoplastic and immunomodulating agents → L03 Immunostimulants → L03A Immunostimulants → L03AA Colony stimulating factors
Discover more medicines within L03AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 5741E, 5742F, 5743G, 5744H, 6126K, 6127L, 6291D, 6292E
Country: CA	Health Products and Food Branch	Identifier(s): 01968017, 02420104, 02420112
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 01975436, 01975442, 02805914, 02805920, 03419314, 03496438, 03496444, 03976457, 05994005, 11653716, 11690255, 17668860, 17668877
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 56-MBE-0516
Country: EE	Ravimiamet	Identifier(s): 1180134, 1180145
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 59102, 64314, 64315
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 167130
Country: FR	Base de données publique des médicaments	Identifier(s): 66663761, 66749096, 69225686
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 311637, 311642, 42067
Country: HK	Department of Health Drug Office	Identifier(s): 35878, 45426, 45427
Country: IE	Health Products Regulatory Authority	Identifier(s): 88120, 88126, 88127, 88128, 88129
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 2843, 4134, 4135
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1004417, 1004418, 1019797, 1019798
Country: NL	Z-Index G-Standaard	Identifier(s): 14165082, 14681900, 14681927
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 32557, 41831, 41858
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 11462, 11782, 6092
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100147295, 100147303, 100147349
Country: SG	Health Sciences Authority	Identifier(s): 06742P, 06743P, 10780P, 10781P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699862950121, 8699862950138
Country: US	FDA, National Drug Code	Identifier(s): 55513-209, 55513-530, 55513-546, 55513-924
Country: ZA	Health Products Regulatory Authority	Identifier(s): 32/30.4/0032, 32/30.4/0033, Z/30.4/190